Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Juha H. O. Turunen"'
Publikováno v:
BMC Public Health, Vol 17, Iss 1, Pp 1-6 (2017)
Abstract Background Varenicline is an efficacious medicine for smoking cessation (SC) but little is known about the characteristics of varenicline users. This study examined the characteristics of first-time (naïve) varenicline users in Finland and
Externí odkaz:
https://doaj.org/article/c0940d76a5984ad4a9ecde7d263ea8a5
Autor:
Alina Shagandina, Tagne Ratassepp, Juha H. O. Turunen, Daisy Volmer, Riitta Ahonen, Jyrki Heinämäki
Publikováno v:
Expert Review of Medical Devices. 12:487-493
To evaluate the current situation on medical technology at community pharmacies in Estonia, looking into the availability, dispensing and counseling of personal medical devices/drug-delivery products (PMDs/DDPs) and related professional knowledge of
Publikováno v:
The Clinical Journal of Pain. 31:79-85
To determine the persistence of chronic pain among community-dwelling older persons and to identify factors related to persistent chronic pain.In this prospective longitudinal study, a random sample of Finnish community-dwelling people aged 76 years
Publikováno v:
BMC Public Health
BMC Public Health, Vol 17, Iss 1, Pp 1-6 (2017)
BMC Public Health, Vol 17, Iss 1, Pp 1-6 (2017)
Background: Varenicline is an efficacious medicine for smoking cessation (SC) but little is known about the characteristics of varenicline users. This study examined the characteristics of first-time (naïve) varenicline users in Finland and compared
Publikováno v:
Age and Ageing. 43:845-850
Background persistent pain is a major problem in older people, but little is known about older persons' opinion about the treatment of persistent pain. Objective the objective of this study was to investigate the factors associated with older partici
Autor:
Piia Peura, Christian Asseburg, Tuija Oksanen, Juha H. O. Turunen, Janne Martikainen, Timo Purmonen
Publikováno v:
International Journal of Technology Assessment in Health Care. 28:382-389
Background: The cost-effectiveness of triptans in the treatment of migraine has not been assessed since generic sumatriptan entered the Finnish market in 2008.Methods: Using systematic review and mixed treatment comparison, the effectiveness of tript
Publikováno v:
International Journal of Pharmacy Practice. 16:91-97
Background and objective Pain is a very common symptom, and it is usually managed pharmacologically. In order to achieve successful pharmacotherapy, the patient must be well informed about various drug-related issues. Our aim was to describe inquirie
Publikováno v:
Pain. 115:374-381
Statistics and prescription database studies show that analgesics are widely utilized, but do not tell anything about either the factors behind analgesic use or how over-the-counter (OTC) analgesics are being used. We aimed to study the prevalence of
Publikováno v:
Clinical therapeutics. 29(3)
Background: Few data are available on whether 3 commonly used, yet slightly different, questionnaire-based measures assessing the use of analgesics provide congruent and comparable results. Objective: The objective of this study was to compare 3 diff
Publikováno v:
The journal of pain. 5(9)
We investigated how a general population treat their pain and determined factors affecting use of different pain management strategies. From the respondents of a cross-sectional postal survey we selected those who had experienced pain during the past